- 专利标题： Insulin analogues and uses thereof
-
申请号： US18541682申请日： 2023-12-15
-
公开(公告)号： US12122818B2公开(公告)日： 2024-10-22
- 发明人: Frantisek Hubalek , Mathias Norrman , Helle Birk Olsen , Peter Madsen , Thomas Boerglum Kjeldsen , Jeppe Sturis
- 申请人： Novo Nordisk A/S
- 申请人地址： DK Bagsvaerd
- 专利权人： Novo Nordisk A/S
- 当前专利权人： Novo Nordisk A/S
- 当前专利权人地址： DK Bagsvaerd
- 代理商 Rosemarie R. Wilk-Orescan
- 优先权： EP 215315 2019.12.11
- 主分类号： C07K14/62
- IPC分类号： C07K14/62 ; A61K47/22 ; A61P3/10
摘要：
The present invention is in the therapeutic field of drugs for medical conditions relating to diabetes. More specifically the invention relates to insulin analogues of human insulin. The invention provides pharmaceutical compositions comprising such insulin analogues and the uses if the such analogues for the treatment or prevention of medical conditions relating to diabetes.
公开/授权文献
- US20240141011A1 NOVEL INSULIN ANALOGUES AND USES THEREOF 公开/授权日：2024-05-02
信息查询
